10 Most Promising Gene Therapy Companies to Watch
Gene therapy is a revolutionary new technology that has followed the growing advances in computing power.
Akouos Inc. (AKUS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Point72 Asset Management Steve Cohen | 0 | $0 | 0% | |
| 2. | Wexford Capital Charles Davidson | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% | ||
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.50 | 29,992,668 | Large Shareholder | 100 | 2022-11-30 | Filing | |
| $17.00 | 294,117 | Large Shareholder | 1,094,101 | 2020-06-30 | Filing | |
| $17.00 | 1,176,000 | Large Shareholder | 1,975,984 | 2020-06-30 | Filing | |
| $17.00 | 825,000 | Large Shareholder | 2,281,249 | 2020-06-30 | Filing | |
| $17.00 | 294,117 | Large Shareholder, Director | 1,094,101 | 2020-06-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 111,648 | Large Shareholder, Director | 982,453 | 2020-12-29 | Filing | |
| $18.00 | 358,352 | Large Shareholder, Director | 3,153,331 | 2020-12-29 | Filing | |
| $18.00 | 111,648 | Large Shareholder | 982,453 | 2020-12-29 | Filing | |
| $18.00 | 358,352 | Large Shareholder | 3,153,331 | 2020-12-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Is AKUS A Good Stock To Buy?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.